The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives
Open accessAbstract
Based on exciting results in animal models, a number of novel immunotherapies employing biotechnological products, rather than conventional immunosuppressants, are being developed for the treatment of multiple sclerosis. The first part of this article is a review of some fundamental concepts of immunology and offers a hypothetical scenario for the immunopathogenesis of multiple sclerosis. The second part provides a critical overview of various immunotherapies relying on modern biotechnology. For each approach, the underlying immunological principles, experimental and clinical evidence, and foreseeable problems are separately addressed. Thus, it is hoped that this article serves a dual purpose, namely to provide an update on recent advances in immunology, and to serve as a useful source of reference to immunotherapies holding promise for future treatment of multiple sclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Nagata, S., & Golstein, P. (1995) · Science · doi:10.1126/science.7533326 · Cited by 3,979
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
Lee, J. C., Laydon, J. T., McDonnell, P. C., Gallagher, T. F., Kumar, S., Green, D., McNulty, D., Blumenthal, M. J., Keys, J. R., Land vatter, S. W., et al. (1994) · Nature · doi:10.1038/372739a0 · Cited by 3,288
Lymphocyte Homing and Homeostasis
Butcher, E. C., & Picker, L. J. (1996) · Science · doi:10.1126/science.272.5258.60 · Cited by 2,846
Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis
Jacobs, L. D., Cookfair, D. L., Rudick, R. A., Herndon, R. M., Richert, J. R., Salazar, A. M., Fischer, J. S., Goodkin, D. E., Granger, C. V., Simon, J. H., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410390304 · Cited by 2,450
The Pathophysiology Of Tumor Necrosis Factors
VASSALLI, P. (1992) · Annual Review of Immunology · doi:10.1146/annurev.immunol.10.1.411 · Cited by 1,920
Johnson, K. P., Brooks, B. R., Cohen, J. A., Ford, C. C., Goldstein, J., Lisak, R. P., Myers, L. W., Panitch, H. S., Rose, J. W., Schiffer, R. B., et al. (1995) · Neurology · doi:10.1212/wnl.45.7.1268 · Cited by 1,898
Lymphocyte responses and cytokines
Paul, W. E., & Seder, R. A. (1994) · Cell · doi:10.1016/0092-8674(94)90332-8 · Cited by 1,828
Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin
Yednock, T. A., Cannon, C., Fritz, L. C., Sanchez-Madrid, F., Steinman, L., & Karin, N. (1992) · Nature · doi:10.1038/356063a0 · Cited by 1,737
The Biology Of Cachectin/TNF: A Primary Mediator Of The Host Response
Beutler, B. (1989) · Annual Review of Immunology · doi:10.1146/annurev.immunol.7.1.625 · Cited by 1,697
Integrins: Emerging Paradigms of Signal Transduction
Schwartz, M. A., Schaller, M. D., & Ginsberg, M. H. (1995) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cb.11.110195.003001 · Cited by 1,594
Acquisition of lymphokine-producing phenotype by CD4+ T cells
Seder, R. A., & Paul, W. E. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.003223 · Cited by 1,557
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
Larsen, C. P., Elwood, E. T., Alexander, D. Z., Ritchie, S. C., Hendrix, R., Tucker-Burden, C., Cho, H. R., Aruffo, A., Hollenbaugh, D., Linsley, P. S., et al. (1996) · Nature · doi:10.1038/381434a0 · Cited by 1,455
Cachectin: More Than a Tumor Necrosis Factor
Epstein, F. H., Beutler, B., & Cerami, A. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702123160705 · Cited by 1,432
Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α
Moss, M. L., Jin, S.-L. C., Milla, M. E., Burkhart, W., Carter, H. L., Chen, W.-J., Clay, W. C., Didsbury, J. R., Hassler, D., Hoffman, C. R., et al. (1997) · Nature · doi:10.1038/385733a0 · Cited by 1,378
Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?
Stein, C. A., & Cheng, Y.-C. (1993) · Science · doi:10.1126/science.8351515 · Cited by 1,303
Treatment of Multiple Sclerosis: A Review
Hauser, S. L., & Cree, B. A. C. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2020.05.049 · Cited by 969
The Three-Dimensional Structure of Peptide-MHC Complexes
Madden, D. R. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.587 · Cited by 842
Tumor Necrosis Factor, Other Cytokines and Disease
Tracey, K. J., & Cerami, A. (1993) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.09.110193.001533 · Cited by 783
Nitric oxide, a novel biologic messenger
Lowenstein, C. J., & Snyder, S. H. (1992) · Cell · doi:10.1016/0092-8674(92)90301-r · Cited by 741
Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions.
Selmaj, K., Raine, C. S., Cannella, B., & Brosnan, C. F. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115102 · Cited by 738
Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis
Lucchinetti, C. F., Brück, W., Rodriguez, M., & Lassmann, H. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00854.x · Cited by 733
Cytokine Signaling Through Nonreceptor Protein Tyrosine Kinases
Taniguchi, T. (1995) · Science · doi:10.1126/science.7716517 · Cited by 692
Sloan-Lancaster, J., & Allen, P. M. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.1 · Cited by 676
Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains
Bö, L., Dawson, T. M., Wesselingh, S., Möurk, S., Choi, S., Kong, P. A., Hanley, D., & Trapp, B. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360515 · Cited by 567
Fas and FasL in the homeostatic regulation of immune responses
Lynch, D. H., Ramsdell, F., & Alderson, M. R. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80079-4 · Cited by 558
T Cell Deletion in High Antigen Dose Therapy of Autoimmune Encephalomyelitis
Critchfield, J. M., Racke, M. K., Zúñiga-Pflücker, J. C., Cannella, B., Raine, C. S., Goverman, J., & Lenardo, M. J. (1994) · Science · doi:10.1126/science.7509084 · Cited by 524
Patterns of oligodendroglia pathology in multiple sclerosis
Ozawa, K., Suchanek, G., Breitschopf, H., Br€ck, W., Budka, H., Jellinger, K., & Lassmann, H. (1994) · Brain · doi:10.1093/brain/117.6.1311 · Cited by 404
Nerve Growth Factor Is an Autocrine Survival Factor for Memory B Lymphocytes
Torcia, M., Bracci-Laudiero, L., Lucibello, M., Nencioni, L., Labardi, D., Rubartelli, A., Cozzolino, F., Aloe, L., & Garaci, E. (1996) · Cell · doi:10.1016/s0092-8674(00)81113-7 · Cited by 394
CTLA-4: a negative regulator of autoimmune disease.
Karandikar, N. J., Vanderlugt, C. L., Walunas, T. L., Miller, S. D., & Bluestone, J. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.783 · Cited by 376
Interleukin‐10 prevents experimental allergic encephalomyelitis in rats
Rott, O., Fleischer, B., & Cash, E. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240629 · Cited by 367
Contenders in FasL/TNF death signaling
Cleveland, J. L., & Ihle, J. N. (1995) · Cell · doi:10.1016/0092-8674(95)90068-3 · Cited by 312
Neuropathology of Multiple Sclerosis
Pfeiffer, J. (1975) · Advances in Neurosurgery · doi:10.1007/978-3-642-66118-1_23 · Cited by 298
Furie, M. B., & Randolph, G. J. (1995) · Europe PMC (PubMed Central) · Cited by 297
Heaney, M., & Golde, D. (1996) · Blood · doi:10.1182/blood.v87.3.847.bloodjournal873847 · Cited by 272
Isolation of myelin basic protein-reactive T-cell lines from normal human blood
Burns, J., Rosenzweig, A., Zweiman, B., & Lisak, R. P. (1983) · Cellular Immunology · doi:10.1016/0008-8749(83)90250-2 · Cited by 266
IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease
Röcken, M., Racke, M., & Shevach, E. M. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80556-1 · Cited by 264
Interferon beta induces interleukin‐10 expression: Relevance to multiple sclerosis
Rudick, R. A., Ransohoff, R. M., Peppler, R., Medendorp, S. V., Lehmann, P., & Alam, J. (1996) · Annals of Neurology · doi:10.1002/ana.410400412 · Cited by 237
Windhagen, A., Schooz, C., Höllsberg, P., Fukaura, H., Sette, A., & Hafler, D. A. (1995) · Immunity · doi:10.1016/1074-7613(95)90145-0 · Cited by 228
Chemokine receptors and T cell chemotaxis.
Mackay, C. R. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.799 · Cited by 215
Khoury, S. J., Akalin, E., Chandraker, A., Turka, L. A., Linsley, P. S., Sayegh, M. H., & Hancock, W. W. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.10.4521 · Cited by 202
Simone, R. D., Giampaolo, A., Giometto, B., Gallo, P., Levi, G., Peschle, C., & Aloisi, F. (1995) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199503000-00004 · Cited by 201
Multiple Sclerosis: Immune System Molecule Expression in the Central Nervous System
Raine, C. S. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199407000-00002 · Cited by 195
Identifying Strategies for Immune Intervention
Lanzavecchia, A. (1993) · Science · doi:10.1126/science.8493532 · Cited by 192
Kojima, K., Berger, T., Lassmann, H., Hinze-Selch, D., Zhang, Y., Gehrmann, J., Reske, K., Wekerle, H., & Linington, C. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.817 · Cited by 188
Weinberg, A. D., BOURDETTE, D. N., Sullivan, T. J., Lemon, M., Wallin, J. J., Maziarz, R. T., Davey, M. P., Palida, F., Godfrey, W. R., Engleman, E. G., et al. (1996) · Nature Medicine · doi:10.1038/nm0296-183 · Cited by 156
Meinl, E., Weber, F., Drexler, K., Morelle, C., Ott, M., Saruhan‐Direskeneli, G., Goebels, N., Ertl-Wagner, B. B., Jechart, G., & Giegerich, G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116879 · Cited by 151
Structure and function of adhesion receptors in leukocyte trafficking
Hogg, N., & Berlin, C. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80147-2 · Cited by 144
Klinkert, W. E. F., Kojima, K., Lesslauer, W., Rinner, W., Lassmann, H., & Wekerle, H. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00183-x · Cited by 134
Thalidomide as an Anti-TNF-α Inhibitor: Implications for Clinical Use
Klausner, J. D., Freedman, V. H., & Kaplan, G. (1996) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1996.0181 · Cited by 125
Human gene therapy — an immature genie, but certainly out of the bottle
Friedmann, T. (1996) · Nature Medicine · doi:10.1038/nm0296-144 · Cited by 118
Inflammation in the nervous system. Basic mechanisms and immunological concepts.
Lassmann, H., Zimprich, F., Rössler, K., et al. (1991) · PubMed · Cited by 103
Immunoglobulins reactive with myelin basic protein promote CNS remyelination
Rodriguez, M., Miller, D. J., & Lennon, V. A. (1996) · Neurology · doi:10.1212/wnl.46.2.538 · Cited by 89
An open trial of OKT3 in patients with multiple sclerosis
Weinshenker, B. G., Bass, B., Karlik, S. J., Ebers, G. C., & Rice, G. P. (1991) · Neurology · doi:10.1212/wnl.41.7.1047 · Cited by 77
Treatment of multiple sclerosis
Ebers, G. C. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91119-3 · Cited by 70
Cytokines and autoantibodies to cytokines
Bendtzen, K., Hansen, M., Ross, C., Poulsen, L. K., & Svenson, M. (1995) · Stem Cells · doi:10.1002/stem.5530130303 · Cited by 62
Beta-interferon and multiple sclerosis
Hall, G. L., Compston, A., & Scolding, N. J. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10071-0 · Cited by 58
Therapeutic Potential of Neurotrophic Factors
McMahon, S. B., & Murinson, B. B. (2005) · Elsevier eBooks · doi:10.1016/b978-012738903-5/50026-6 · Cited by 2
Cited by
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 2,899
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724
T cell subsets and their signature cytokines in autoimmune and inflammatory diseases
Raphael, I., Nalawade, S., Eagar, T. N., & Forsthuber, T. G. (2015) · Cytokine · doi:10.1016/j.cyto.2014.09.011 · Cited by 1,160
Kerschensteiner, M., Gallmeier, E., Behrens, L., Leal, V. V., Misgeld, T., Klinkert, W. E. F., Kolbeck, R., Hoppe, E., Oropeza-Wekerle, R.-L., Bartke, I., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.865 · Cited by 1,019
Self-citation
Metadata
- Authors
- Hohlfeld, R.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-05-01
- Volume
- 120
- Issue
- 5
- Pages
- 865-916
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2036164613
- Cited by
- 365
- References
- 58
- FWCI
- 17.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.